Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2010; 56(1): 30-40


The association of [sup]-1082[/sup]a ->g polymor-phism of il-10 and ([sup]-308[/sup]a ->g) polymor-phism of tnf alpha genes with bone densi-ty in elderly women

І.М. Pishel, О.О. Yevtushenko, Yu.І. Leonov,N.V. Grygoryeva, Т.V. Orlyk, D.V.Shytikov,V.V. Povoroznyuk, G.М. Butenko.

    Institute of Gerontology of AMS of Ukraine, Kyiv


Abstract

We studied the association between disturbances of structure and function in bone tissue and (-1082A -> G) polymorphism of IL-10 and (-308A -> G) polymorphism of TNFб genes. SNP-polymerase cyclic reaction was used. The study failed to find significant influence of (-308A -> G) TNF6 polymorphism on the development of bone tissue pathology in postmenopausal women. The patients with AA genotype of -1082A/G IL-10 gene have significantly lower indices of bone density comparing with G allele carriers (GG/AG). This association remained true both for bone tissue density of whole body, and for sepa­rate parts of skeleton: lumbar spine, femur neck, Ward zone of hip bone. Our study indicates that (-308A -> G) polymorphism of TNFa gene is not associated with structural-functional changes in bone tissue in Ukrainian population. However, there is strong evidence that women who carries the AA geno­type of -1082A/G polymorphism of IL-10 gene have signifi­cantly lower bone tissue density. This indicates the potentialfor predictive genetic testing of osteoporosis risk. Analyses of gene combination IL-10 -1082G/G and TNFa -308G/G («anti­inflammatory genotype») did not show any significant asso­ciation of this genotype with bone tissue characteristics, which shows low predictive value of this combination for diagnos­tics of structural-functional state of bone tissue.

Keywords: gene polymorphisms, bone tissue, aging, IL-10,TNF

References

  1. Бутенко Г.М. Остеопороз и иммунная система // Проблеми остеології. - 1999. - 2, №3. - С.23-28.
  2. Bajnok E., Takacs I., Vargha P. et al. Lack of associa­tion between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women // Bone. - 2000. -27,№3. - P.559-562.
  3. Bayley J.P., Ottenhoff T.H., Verweij C.L. Is there a future for TNF promoter polymorphisms // Genes Immun. - 2004. - 5, № 1. - P.315-329.
  4. Bruunsgaard H., Pedersen B.K. Age-related inflam­matory cytokines and disease // Immunol. Allergy Clin. Nrth Am. - 2003. - 23, №1. - P.15-39.
  5. Chen H.Y., Chen W.C., Wu M.C. et al. Interleukin-1beta and interleukin-1 receptor antagonist gene poly­morphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporo­sis // Maturitas. - 2002. - 44, № 1. - P.49-54.
  6. Duncan E.L., Brown M.A., Sinsheimer J. et al. Sugges­tive linkage of the parathyroid receptor type 1 to os­teoporosis // J. Bone Miner. Res. - 1999. - 14, № 12. -P.1993-1999.
  7. Eisman J.A. Genetics of osteoporosis // Endocrine Rev. -2000. - 20, № 6. - P.788-804.
  8. Ferrari S.L., Ahn-Luong L., Garnero P. et al. Two pro­moter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women // J. Clin. Endocrinol. Metab. -2003. - 88,№1. - P.255-259.
  9. 9. Ferrari S.L., Garnero P., Emond S. et al. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women // Arthritis Rheum. - 2001. - 44, № 1. - P.196-201.
  10. 10. Fowler E., Eri R., Hume G. et al. TNF{alpha} and IL10 SNPs act together to predict disease behaviour in Crohn’s disease // J. Med. Genetics. - 2005. - 42, № 2. -P.523-528.
  11. Gallagher P.M., Lowe G., Fitzgerald T. et al. Associa­tion of IL-10 polymorphism with severity of illness in community acquired pneumonia // Thorax. - 2003. -58,№1. - P.154-156.
  12. Giacconi R., Cipriano C, Albanese F.C.A. The 174G/ C polimorphism of IL-6 is useful to screen old sub- jects at risk for atherosclerosis or to reach successful ageing // Exp. Gerontol. - 2004. - 39, № 4. - P.621-628.
  13. Ginaldi L., De Martinis M., Monti D., Franceschi C. Chronic antigenic load and apoptosis in immuno-senescence // Trends Immunol. - 2005. - 26, № 1. -P.79-84.
  14. Ginaldi L., DiBenedetto M.C, DeMartinis M. Os­teoporosis, inflammation and aging // Immunity & Age­ing. - 2005. - 2, № 1. - P.14-27.
  15. Gong M.N., Thompson B.T., Williams P.L. et al. Interleukin-10 polymorphism in position - 1082 and acute respiratory distress syndrome // Eur. Respir. J. -2006. - 27,№3. - P.674-681.
  16. Gonzalez S., Rodrigo L., Martinez-Borra J. et al. TNF-a-308A promoter polymorphism is associated with enhanced TNF-a production and inflammatory activ­ity in Crohn’s patients with fistulizing disease // Amer. J. Gastroenterol. - 2003. - 98, № 1. - P.1101-1111.
  17. Haider A.S., Lowes M.A., Su6rez-Faricas M. et al. Iden­tification of cellular pathways of «Type 1,» Th17 T cells, and TNF- and inducible Nitric Oxide Synthase-produc-ing dendritic cells in autoimmune inflammation through pharmacogenomic study of Cyclosporine A in psoriasis // J. Immunol. - 2008. - 180, № 3. - P.1913-1920.
  18. Hajeer A.H., Hutchinson I. Influence of TNF-б gene polymorphisms on TNF-a production and disease // Hum. Immunol. - 2001. - 62, № 4. - P.1191-1199
  19. 19. Hirose K., Tomiyama H., Okazaki R. et al. Increased pulse wavevelocity associated with reduced calcaneal quantitative osteo-sono index: possible relationship between atherosclerosis and osteopenia // J. Clin. Endocrinol. Metab. - 2003. - 88, № 6. - P.2573-2578.
  20. 20. Hofbauer L.C., Gori F., Riggs B.L. et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of gluco-corticoid-induced osteoporosis // Endocrinology. -1999. - 140,№5. - P.4382-4389.
  21. Katagiri T., Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation // Oral. Dis. -2002. - 8,№1. - P.147-159.
  22. Krishnamurthy P., Rajasingh J., Lambers E. et al. IL-10 Inhibits inflammation and attenuates left ventricu­lar remodeling after myocardial infarction via activa­tion of STAT3 and suppression of HuR // Circulat. Res. - 2009. - 104, №1. - P.e9 - e18.
  23. Langdahl B.L., Knudsen J.Y., Jensen H.K. et al. A se­quence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and in­creased bone turnover in both osteoporotic and normal women // Bone. - 1997. - 20, № 1. - P.289-294.
  24. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis // Endo­crine Rev. - 2000. - 21, № 2. - P.115-137.25. Manolagas S.C., Weinstein R.S. New developments in the pathogenesis and treatment of steroid-induced os­teoporosis // J. Bone Miner. Res. - 1999. - 14, № 6. -P.1061-1066.
  25. Mencej S., Albagha O.M.E., Janez Preelj. et al. Tu­mour necrosis factor superfamily member 11 gene pro­moter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis // J. Mol. Endocrin. - 2008. -40,№1. - P.273-279.
  26. Moffett S.P., Zmuda J.M., Oakley J.I. et al. Tumor necro­sis factor-a polymorphism, bone strength phenotypes, and the risk of fracture in older women // J. Clin. Endocrin. & Metabol. - 2005. - 90, №. 6. - P.3491-3497.
  27. Monneret G., Finck M.E., Venet F. et al. The anti­inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration // Immunol. Lett. -2004. - 95,№1. - P.193-198.
  28. 29. Nanes M.S. Tumor necrosis factor- б molecular and cellular mechanisms in skeletal pathology // Gene. -2003. - 321,№1. - P.1 - 15.
  29. 30. Oberholzer A., Oberholzer C, Moldawer L.L. Interleukin-10: a complex role in the pathogenesis of sepsis syn­dromes and its potential as an anti-inflammatory drug // Crit. Care. Med. - 2002. - 30, № 1. - P. S58-S63.
  30. Ota N., Hunt S.C., Nakajima T. et al. Linkage of human tumor necrosis factor-alpha to human osteoporosis by sib pair analysis // Genes. Immun. - 2000. - 1, № 4. -P.260-264.
  31. Owens J.M., Gallagher A.C., Chambers T.J. IL-10 modu­lates formation of osteoclasts in murine hemopoietic cultures // J. Immunol. - 1996. - 157, № 2. - P.936-945.
  32. Palmeri S., Lio D., Vaglica M. et al. Caruso Analysis of interleukin 10 (IL-10)-1082G/A single nucleotide poly­morphism (SNP) genotypes in breast cancer (BC) pa­tients (pts) and in >95 years old cancer free women // J. Clin. Oncol. - 2005. - 23, S 16. - P.9656-9664.
  33. Poli , Balena R., Fattori E. et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion // EMBO J. - 1994. - 13, №10. - P.1189-1196.
  34. Prevention and management of osteoporosis. - WHO: Geneva, 2003. - 192 p.
  35. Ralston S.H. Genetic control of susceptibility to os­teoporosis // J. Clin. Endocrinol. Metab. - 2002. - 87, № 6. - P.2460-2466.
  36. Reuss E., Fimmers R., Kruger A. et al. Differential regulation of interleukin-10 production by genetic and environmental factors-a twin study // Genes Immunol. -2002. - 3,№2. - P.407-413.
  37. Roubenoff R. Catabolism of aging: is it an inflammatory process // Curr. Opin.Clin. Nutr. Metab. Care. - 2003. -6,№1. - P.295-299.
  38. 39. Sasaki H., Hou L., Belani A. et al. IL-10, but №t IL-4, suppresses infection-stimulated bone resorption in vivo // J. Immunol. - 2000. - 165, № 9. - P.3626-3630.
  39. 40. Schulte C.M., Dignass A.U., Goebell H. et al. Genetic factors determine extent of bone loss in inflammatory bowel disease // Gestroenterology. - 2000. - 119, № 4. - P.909-1020.
  40. Seeman E. Physiology of aging invited review: Patho­genesis of osteoporosis // J. Appl. Physiol. - 2003. -95,№12. - P.2142-2151.
  41. Shi X.M., Chang Z.J., Blair H.C. et al. Glucocorti­coids induce adipogenesis of stromal cells by tran­scriptionally activating PPARy2 // Bone. - 1998. - 23, S6. - P.S454-S462.
  42. Suarez A., Castro P., Alonso R. et al. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with ge­netic polymorphisms // Transplantation. - 2003. - 75, №3. - P.711-717.
  43. Takacs I., Koller DL., Peacock M. et al. Sib pair link­age and association studies between bone mineral den­sity and the interleukin-6 gene locus // Bone. - 2000. -27,№1. - P.169-173.
  44. Wallin R., Wajih N., Greenwood G.T., Sane D.C. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy // Med. Res. Re -2001. - 21,№1. - P.274-301.
  45. Weitzmann M.N., Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale // J. Clin. Invest. -2006. - 116, № 4. - P.1186-1194.
  46. Yun A.J., Lee P.Y. Maladaptation of the link between inflammation and bone turnover may be a key determi­nant of osteoporosis // Med. Hypotheses. - 2004. -63, № 2. - P.532-537.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.